Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Everbright

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 46
Average round size
info
The average size of a deal this fund participated in
$82M
Portfolio companies 36
Rounds per year 1.70
Lead investments 6
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.22
Exits 4
Key employees 17
Stages of investment
Early Stage Venture

Areas of investment

  • Software
  • Information Technology
  • Biotechnology
  • Health Care
  • Internet of Things
Summary

Everbright appeared to be the Corporate Investor, which was created in 1997. The venture was found in Asia in Hong Kong. The main department of described Corporate Investor is located in the Hong Kong.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Everbright, startups are often financed by Versant Ventures, Venrock, Tavistock Life Sciences. The meaningful sponsors for the fund in investment in the same round are IDG Capital, Source Code Capital, HOPU Investment Management Company. In the next rounds fund is usually obtained by JD.com, Warburg Pincus, WANDA Group.

The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight Terminus Technologies, Ambrx, Googut Wine & Spirits. Among the most popular fund investment industries, there are Video Streaming, Health Care. For fund there is no match between the country of its foundation and the country of its the most frequent investments - China. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

The important activity for fund was in 2019. Speaking about the real fund results, this Corporate Investor is 15 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of more than 100 millions dollars. The fund is constantly included in 2-6 investment rounds annually. The typical startup value when the investment from Everbright is more than 1 billion dollars. This Everbright works on 19 percentage points less the average amount of lead investments comparing to the other organizations.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Everbright:
Typical Co-investors
Everbright is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Everbright:

Funds with similar focus

Funds from China
Funds with similar focus located in China:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Centrecourt Asset Management New York, New York, United States
Charme Capital Partners Italy, Lombardia, Milano
Digital Surgeons Connecticut, New Haven, United States
DK Gate Japan, Tokyo
FortisBC British Columbia, Canada, Surrey
Galapagos Belgium, Limburg, Mechelen-bovelingen
Galitt Boulogne-Billancourt, France, Ile-de-France
Impression Ventures Canada, Ontario, Toronto
Karst Peak Capital China, Hong Kong, Hong Kong Island
Newlight Management New York, New York, United States
Planeta Securitizadora Agro Brazil, São Paulo, Sao Paulo
Portage Biotech Canada, Ontario, Toronto
RFF Vest -
Rohatton -
Sightline Healthcare Opportunity -
Tokio Marine Capital Chiyoda, Japan
ULIXE Group Italy, Piemonte, Torino
Warisan Investment Partners Switzerland, Zug, Zug
Zhaopin Beijing, Beijing, China

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Reforgene Medicine

Biotechnology
Health Care
Medical
Therapeutics
$15M28 Apr 2023 Guangzhou, Guangdong, China

Grit Science

$15M02 Mar 2022 -

Innogen Pharmaceutical

Biopharma
Biotechnology
Pharmaceutical
$120M23 Dec 2021 Shanghai, Shanghai, China

Jiuduuoduo

Cooking
Food and Beverage
Food Processing
Livestock
Manufacturing
$16M29 Oct 2021 -

IASO Biotherapeutics

Biotechnology
Pharmaceutical
$108M16 Sep 2021 Xuanwu District, Jiangsu, China

Dedao

$3M29 Oct 2020 Hebei, Hebei, China

T11 Food Market

Grocery
Retail
$14M27 Apr 2020 Dongcheng District, Beijing, China

Yeelight

Electronics
Internet of Things
Manufacturing
$28M16 Apr 2020 China, Wuwei

Juvenile Get

E-Learning
Education
$15M14 Nov 2019 -
News
IASO Biotherapeutics Secures $108 Million Series C Funding to Advance Global Development of Innovative Cell Therapies

– IASO Biotherapeutics announced the completion of $108m Series C to advance the global development of novel cell therapies and biologics for oncology and autoimmune diseases.
– The round was led by CDH Baifu, and followed by CCB International, with strong participation from Everbright Limited, Co-Stone Capital, CNCB Capital and Plaisance Capital.
– Current shareholder GL Ventures also participated.
– Since its founding in 2017, IASO Bio has raised more than $178m.
– Proceeds from the financing will be used to accelerate the global development and regulatory submissions of multiple novel cell therapies.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Everbright?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 46
Average round size 82M
Rounds per year 1.70
Peak activity year 2018
Lead investments 6
Follow on index 0.22
Exits 4
Group Appearance index 0.85

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Reforgene Medicine

Biotechnology
Health Care
Medical
Therapeutics
$15M28 Apr 2023 Guangzhou, Guangdong, China

Grit Science

$15M02 Mar 2022 -

Innogen Pharmaceutical

Biopharma
Biotechnology
Pharmaceutical
$120M23 Dec 2021 Shanghai, Shanghai, China

Jiuduuoduo

Cooking
Food and Beverage
Food Processing
Livestock
Manufacturing
$16M29 Oct 2021 -

IASO Biotherapeutics

Biotechnology
Pharmaceutical
$108M16 Sep 2021 Xuanwu District, Jiangsu, China

Dedao

$3M29 Oct 2020 Hebei, Hebei, China

T11 Food Market

Grocery
Retail
$14M27 Apr 2020 Dongcheng District, Beijing, China

Yeelight

Electronics
Internet of Things
Manufacturing
$28M16 Apr 2020 China, Wuwei

Juvenile Get

E-Learning
Education
$15M14 Nov 2019 -
Crunchbase icon

Content report

The following text will be sent to our editors: